Education
About Us
Working with TipRanks
Follow Us
Revive Therapeutics (TSE:RVV)
:RVV
RESEARCH TOOLSreports
RVV Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume2.50K
Average Volume (3M)134.42K
Market Cap
C$10.46M
Enterprise ValueC$13.40M
Total Cash (Recent Filing)C$55.41K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta2.00
Next Earnings
Oct 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding418,564,270
10 Day Avg. Volume264,752
30 Day Avg. Volume134,421
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.43
Price to Sales (P/S)0.00
P/FCF Ratio-2.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revive Therapeutics News
PremiumCompany Announcements
Revive Therapeutics Advances Next-Gen Bucillamine for Critical Medical Needs
PremiumCompany Announcements
Revive Therapeutics Advances Bucillamine Research for Nerve Agent Exposure
PremiumCompany Announcements
Revive Therapeutics Announces Shares for Debt Transaction to Preserve Cash
PremiumCompany Announcements
Revive Therapeutics Explores Bucillamine’s Role in Cancer Treatment
PremiumCompany Announcements
Revive Therapeutics Expands Pipeline with Molecular Hydrogen AcquisitionOptions Prices
Currently, No data available
---
Ownership Overview
0.88% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.12% Public Companies and
Individual Investors
RVV FAQ
What was Revive Therapeutics’s price range in the past 12 months?
Revive Therapeutics lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Revive Therapeutics’s market cap?
Revive Therapeutics’s market cap is C$10.46M.
When is Revive Therapeutics’s upcoming earnings report date?
Revive Therapeutics’s upcoming earnings report date is Oct 27, 2025 which is in 135 days.
How were Revive Therapeutics’s earnings last quarter?
Revive Therapeutics released its earnings results on May 30, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Revive Therapeutics overvalued?
According to Wall Street analysts Revive Therapeutics’s price is currently Overvalued.
Does Revive Therapeutics pay dividends?
Revive Therapeutics does not currently pay dividends.
What is Revive Therapeutics’s EPS estimate?
Revive Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revive Therapeutics have?
Revive Therapeutics has 418,564,270 shares outstanding.
What happened to Revive Therapeutics’s price movement after its last earnings report?
Revive Therapeutics reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 50%.
Which hedge fund is a major shareholder of Revive Therapeutics?
Currently, no hedge funds are holding shares in TSE:RVV
Company Description
Revive Therapeutics
Revive Therapeutics Ltd. is a life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. Operating primarily in the biopharmaceutical sector, the company is committed to the advancement of innovative treatments leveraging its unique platform to address unmet medical needs in areas such as infectious diseases, rare disorders, and chronic pain management.